Glucocorticoid-induced osteoporosis update
Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
July 2019 - Volume 31 - Issue 4 Previous Article Next Article METABOLIC BONE DISEASE:
Edited by Stephen Honig Glucocorticoid-induced osteoporosis update Adami, Giovanni; Saag,
Kenneth G. Author Information a Division of Clinical Immunology and Rheumatology …
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
July 2019 - Volume 31 - Issue 4 Previous Article Next Article METABOLIC BONE DISEASE:
Edited by Stephen Honig Glucocorticoid-induced osteoporosis update Adami, Giovanni; Saag,
Kenneth G. Author Information a Division of Clinical Immunology and Rheumatology …
Summary
GIOP and fragility fractures are important adverse events related to the long-term use of glucocorticoids. Recent studies have provided additional data on the epidemiology and pathogenesis of GIOP and on the efficacy and effectiveness of GIOP therapies.
Lippincott Williams & Wilkins